Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/1996
05/01/1996EP0708642A1 Taxol derivatives
05/01/1996EP0708641A1 Use of nabumetone or 6-methoxynaphthyl acetic acid for the treatment of dementia
05/01/1996EP0708640A1 Pharmaceutical preparations with an active principle containing modified amidin groups
05/01/1996EP0708639A1 Methods and compositions for treating depression and other disorders using optically pure (+) sibutramine
05/01/1996EP0708638A1 Methods and compositions for treating depression and other psychiatric disorders
05/01/1996EP0708637A1 Self-assembling polynucleotide delivery system comprising dendrimer polycations
05/01/1996EP0708636A1 Pack for use in, and method of hormonal replacement therapy
05/01/1996EP0708627A1 Method and device for providing nicotine replacement therapy transdermally/transbuccally
05/01/1996EP0708592A1 Mts gene, mutations therein, and methods for diagnosing cancer using mts gene sequence
05/01/1996EP0606386B1 Dermatological and/or cosmetological composition containing retinoids
05/01/1996EP0519926B1 Transdermal system
05/01/1996EP0479850B1 Preparation for topical treatment of infections caused by virus, bacteria and fungi
05/01/1996EP0467954B1 Preparation of liposome and lipid complex compositions
05/01/1996EP0457883B1 New bicyclic amino-substituted compounds
05/01/1996CN1121722A Spirostanyl glycosidal crystalline monohydrate
05/01/1996CN1121721A Oligonucleotido alky phosphate and alky substituted phosphate
05/01/1996CN1121720A Pyrido(1,2,3-de)quinoxaline derivatives, process for preparing the same and their use in medicaments
05/01/1996CN1121719A Risperidone pamoate
05/01/1996CN1121718A Heterocyclic derivatives
05/01/1996CN1121717A Heterocyclic compounds and their preparation and use
05/01/1996CN1121715A 4-aryl-4-hydroxy-tetrahydropyrans and 3-aryl-3-hydroxy-tetrahydrofurans as 5-lipoxygenase inhibitors
05/01/1996CN1121714A Novel 5-pyrrolyl-2-pyridylmethylsulfinyl benzimidazole derivatives
05/01/1996CN1121710A Heterocyclic compounds, their use and preparation
05/01/1996CN1121707A Unsaturate amino compounds for use as anticancer and antiprotozoic agent
05/01/1996CN1121693A Oesteoblast growth stimulating composition containing PDGF and vitamin D
05/01/1996CN1121692A Composition containing cholestyramine and method of producing the same
05/01/1996CN1121691A Stabilized injection and method of stabilizing injection
05/01/1996CN1121690A Use of thiazolidinediones for the treatment of atherosclerosis and eating disorders
05/01/1996CN1121689A Use of indole derivatives as 5HT1 antagonists
05/01/1996CN1121688A Stable, ingestable and absorbable NADH and NADPH therapeutic compositions
05/01/1996CN1121683A Ionene polymers as microbicides
05/01/1996CN1121429A Endoparasiticidal compositions
05/01/1996CN1121414A Pharmaceutical containing noval 3,7-diazabicyclic |3,31¨-non-bilinking compound
05/01/1996CN1121413A Antimicrobial composition
05/01/1996CN1121412A Compositions containing piperine
05/01/1996CN1031713C Process for preparing 9-purinyl phosphonic acid derivatives
05/01/1996CN1031710C Process for preparing quinoline carboxylic acid boric acid anhydride
05/01/1996CN1031709C Process for preparing new 3,4-dehydropiperidine derivatives and their salt
05/01/1996CN1031705C Process for preparing 24-homo-vitamin-D-derivatives
05/01/1996CA2161618A1 Benzylpiperidine derivatives
04/1996
04/30/1996US5512683 Osteoporosis, immunosuppressant
04/30/1996US5512681 Angiotensin II receptor blocking imidazolinone derivatives
04/30/1996US5512675 Methods for preparing porphyrin-like compounds
04/30/1996US5512658 Pseudomonas exotoxins (PE) and conjugates thereof having lower animal toxicity with high cytocidal activity through substitution of positively charged amino acids
04/30/1996US5512598 Dietary vaccine for inhibiting metabolism of methanol
04/30/1996US5512597 Polymeric quaternary ammonium compounds and their use as ophthalmic antimicrobials
04/30/1996US5512596 Aromatic compounds
04/30/1996US5512595 Substituted phenoxyisobutyric acids and esters
04/30/1996US5512594 Administering to treat a medical condition mediated by one or more leukotrienes
04/30/1996US5512593 Composition and method of treating depression using natoxone or naltrexone in combination with a serotonin reuptake inhibitor
04/30/1996US5512592 Method of producing cardiotonic effect and improving cardiac contractile function by administration of carnosine
04/30/1996US5512591 Treatments for diseases characterized by neovascularization
04/30/1996US5512590 Prevents disorder of gabaergic transmission
04/30/1996US5512588 Antiulcer agents
04/30/1996US5512587 Method for treating opiate withdrawal
04/30/1996US5512583 Methods of decreasing serum calcium levels
04/30/1996US5512581 Antiinflammatory agent
04/30/1996US5512580 Method and compositions for maintaining glomerular filtration rate while inhibiting extracellular matrix accumulation
04/30/1996US5512579 Aminobenzoic acid derivatives
04/30/1996US5512578 Administering bimodally-acting opioid agonist and excitatory opioid receptor antagonist
04/30/1996US5512577 Bicyclic hexahydroaporphine and 1-benzyloctahydroisoquinoline therapeutic compositions and processes for utilizing said compositions
04/30/1996US5512576 2-substituted 1,2,5,-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
04/30/1996US5512574 Treating neurological and mental illnesses, such as alzheimer's
04/30/1996US5512573 Skin irritation; prevention transplant rejection
04/30/1996US5512572 Using ((4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)-phenyl) hydrazono)propanedinitrile
04/30/1996US5512571 Diastereomeric intermediates which form levorotatorycardiotonic agents having high bioavailability
04/30/1996US5512570 Treatment of emesis with morpholine tachykinin receptor antagonists
04/30/1996US5512569 Aminoalkyl benzothiazolinones
04/30/1996US5512568 For treating a mammal having a disease state that is alleviated by treatment with an inosine 5'-monophosphate dehydrogenase inhibitor
04/30/1996US5512566 Useful in treating diseases of central nervous system
04/30/1996US5512564 Tricyclic thiazole and oxazole derivatives and pharmaceutical agents containing them
04/30/1996US5512563 Tricyclic benzazepine vasopressin antagonists
04/30/1996US5512562 Tricyclic 2,3,4,5-tetrahydro-1H-3-benzapines
04/30/1996US5512559 Method of treating cancer tumors with imine porphyrin compounds
04/30/1996US5512558 Nor-bile acid derivatives, processes for their preparation and the use of these compounds as medicaments
04/30/1996US5512557 Coronary heart disease treated with 17βoestradiol
04/30/1996US5512556 For the prevention and treatment of mammary tumors
04/30/1996US5512555 Administering a composition containing 5 alpha-reductase inhibitors and antiperspirant
04/30/1996US5512553 Preventing or treating bacterial infections
04/30/1996US5512552 Bone resorption inhibitor; osteoporosis
04/30/1996US5512438 Inhibiting RNA expression by forming a pseudo-half-knot RNA at the target's
04/30/1996US5512431 Methods of screening for nucleoside analogs that are incorporated by HIV reverse transcriptase and cause incorrect base pairing
04/30/1996US5512303 Injectable pharmaceutical composition
04/30/1996US5512302 Pharmaceutical process using starch
04/30/1996US5512300 Heating to form a melt, combining with alkali metal to forge amalgamation, mixing into homogeneous paste for inclusion in a compound without disrupting
04/30/1996US5512298 Cytarabine ocfosfate hard capsule
04/30/1996US5512296 Methods for inhibiting neuronal damage
04/30/1996US5512292 Transdermal contraceptive formulations methods and devices
04/30/1996US5512289 Spermicidal anti-viral lubricant composition and method of using same
04/30/1996US5512286 Extract from leaves of ginkgo biloba for intravenous injection or infusion
04/30/1996US5512284 Method for treating bacterial infections
04/30/1996US5512270 Respiratory system disorders, parkinson's disease, gastrointestinal disorders
04/30/1996US5512269 Method of treating retained pulmonary secretions
04/30/1996US5512177 Narrow poly- and mono-dispersed anoinic oligomers, and their uses, formulations and process
04/30/1996CA2027783C 3-aryloxazolidinone derivatives, process for their preparation and their use in therapy
04/30/1996CA2027782C 3-aryloxazolidinone derivatives, process for their preparation and their use in therapy
04/30/1996CA2026278C Use of alkylphosphoric acid compounds for combatting psoriasis disorders
04/30/1996CA1338287C Hetrazepines and processes for preparing them
04/28/1996CA2161490A1 Steroids with a 17-spiromethylene lactone or lactol group
04/27/1996CA2161399A1 Package for a veterinary implant
1 ... 6922 6923 6924 6925 6926 6927 6928 6929 6930 6931 6932 6933 6934 6935 6936 6937 6938 6939 6940 6941 6942 ... 7860